• Title/Summary/Keyword: Vero E6 Cell

Search Result 21, Processing Time 0.023 seconds

Electron Microscopic Study on the Replcation of Hantaan Virus in Vero-E6 Cells (Vero-E6 세포에서 한탄바이러스의 증식에 관한 전자현미경적 연구)

  • Park, Kyung-Hee;Seong, In-Wha
    • The Journal of Korean Society of Virology
    • /
    • v.29 no.4
    • /
    • pp.201-209
    • /
    • 1999
  • Results of the studies on the morphologic and molecular biologic characteristics of Hantaan virus (HTNV), one of the etiologic agents of Hemorrhagic fever with renal syndrome (HFRS), revealed that HTNV was a member of Family Bunyaviridae and its RNA divided into three segments. And the nucleotide sequences of these segments also were known and the differences in nucleotide sequences of HTNV from other members of genus Hantavirus were clearly evaluated. But the morphorgenesis, pathogenesis of HFRS and the replication time had not been clearly determined. In this study, to estimate the replication time of HTNV in Vero E-6 cells, Vero cells were infected with HTNV 76/118 strain, and cells were harvested from two hours post-infection up to 24 hours at two hours-intervals. Harvested cells were treated with ordinary techniques for electron microscopy and immune-electron microscopy. And then thin sections were observed under transmission electron microscope. HTNV particles were not found in the cytoplasm and in the extracellular space between $2{\sim}8$ hours after inoculation of virus, but virus particles were observed in extracellular space near the cell membrane of Vero-E6 cells 10 hours after infection. In immune electron microscopy, mature HTNV particles in extracellular spaces and immature virus labelled with gold particles in the cytoplasm of Vero E-6 cell 10 hours after infection of HTNV could be seen. This results suggest that the replication time of HTNV might be about 10 hours.

  • PDF

Defining the N-Linked Glycosylation Site of Hantaan Virus Envelope Glycoproteins Essential for Cell Fusion

  • Zheng, Feng;Ma, Lixian;Shao, Lihua;Wang, Gang;Chen, Fengzhe;Zhang, Ying;Yang, Song
    • Journal of Microbiology
    • /
    • v.45 no.1
    • /
    • pp.41-47
    • /
    • 2007
  • The Hantaan virus (HTNV) is an enveloped virus that is capable of inducing low pH-dependent cell fusion. We molecularly cloned the viral glycoprotein (GP) and nucleocapsid (NP) cDNA of HTNV and expressed them in Vero E6 cells under the control of a CMV promoter. The viral gene expression was assessed using an indirect immunofluorescence assay and immunoprecipitation. The transfected Vero E6 cells expressing GPs, but not those expressing NP, fused and formed a syncytium following exposure to a low pH. Monoclonal antibodies (MAbs) against envelope GPs inhibited cell fusion, whereas MAbs against NP did not. We also investigated the N-linked glycosylation of HTNV GPs and its role in cell fusion. The envelope GPs of HTNV are modified by N-linked glycosylation at five sites: four sites on G1 (N134, N235, N347, and N399) and one site on G2 (N928). Site-directed mutagenesis was used to construct eight GP gene mutants, including five single N-glycosylation site mutants and three double-site mutants, which were then expressed in Vero E6 cells. The oligosaccharide chain on residue N928 of G2 was found to be crucial for cell fusion after exposure to a low pH. These results suggest that G2 is likely to be the fusion protein of HTNV.

In Vitro Antineoplastic Effects of Chitosan Hydrolysates on Various Tumor Cell Lines (키토산 가수분해물의 In Vitro 항종양성)

  • Park, Heon-Kuk
    • The Korean Journal of Food And Nutrition
    • /
    • v.22 no.4
    • /
    • pp.639-643
    • /
    • 2009
  • In this study, the antineoplastic effects of chitosan hydrolysates were assessed. The chitosan hydrolysates showed no cytotoxicity in in vitro trials using the normal cell line, Vero E6(Africa green monkey kidney cells). The $IC_{50}$ value of the chitosan hydrolysates on Vero E6 was 1,107.95 ${\mu}g/m{\ell}$. The hydrolysates exhibited in vitro antineoplastic activity in five human tumor (lung carcinoma, bladder carcinoma, colon carcinoma, stomach carcinoma, breast carcinoma) cell lines. The $IC_{50}$ values of the hydrolysates on A549, J82, SNU-C4, SNU-1, and ZR75-1 cells were 421.06, 417.99, 445.54, 380.65 and 460.49 ${\mu}g/m{\ell}$, respectively.

Attenuated Expression of Interferon-induced Protein Kinase PKR in a Simian Cell Devoid of Type I Interferons

  • Park, Se-Hoon;Choi, Jaydo;Kang, Ju-Il;Choi, Sang-Yun;Hwang, Soon-Bong;Kim, Jungsuh P.;Ahn, Byung-Yoon
    • Molecules and Cells
    • /
    • v.21 no.1
    • /
    • pp.21-28
    • /
    • 2006
  • The interferon-induced, double-stranded RNA (dsRNA)-dependent protein kinase PKR plays a key role in interferon-mediated host defense against viral infection, and is implicated in cellular transformation and apoptosis. We have isolated a cDNA of simian PKR encoding a product with 83% amino acid identity to the human homolog and showed that PKR expression is significantly attenuated in the Vero E6 African green monkey kidney cells devoid of type I interferon genes. A variant form of PKR lacking the exon 12 in the kinase domain is produced in these cells, presumably from an alternatively spliced transcript. Unlike wild type PKR, the variant protein named PKR-${\Delta}E12$ is incapable of auto-phosphorylation and phosphorylation of eIF2-${\alpha}$, indicating that the kinase sub-domains III and IV embedded in exon 12 are indispensable for catalytic function. PKR-${\Delta}E12$ had no dominant negative effect but was weakly phosphorylated in trans by wild type PKR.

Antineoplastic Effect of Low Molecular Weight Chitooligosaccharide on Various Tumor Cell Lines (저분자량 키토산 올리고당의 항종양성)

  • Park, Heon-Kuk
    • The Korean Journal of Food And Nutrition
    • /
    • v.22 no.2
    • /
    • pp.308-312
    • /
    • 2009
  • In this study, the effects of low molecular weight chitooligosaccharides were assessed. Low molecular weight chitooligosaccharide evidenced no cytotoxicity in in vitro trials with the normal cell line, Vero E6(Africa green monkey kidney cell). The $IC_{50}$ of low molecular weight chitooligosaccharide was $923.20{\mu}g/m{\ell}$. Low molecular weight chitooligosaccharide exhibited in vitro antineoplastic activity in five human tumor(lung carcinoma, bladder carcinoma, colon carcinoma, stomach carcinoma, breast carcinoma) cell lines. The $IC_{50}$ values of low molecular weight chitooligosaccharide on A549, J82, SNU-C4, SNU-1 and ZR75-1 were $477.42{\mu}g/m{\ell}$, $480.40{\mu}g/m{\ell}$, $436.84{\mu}g/m{\ell}$, $373.55{\mu}g/m{\ell}$, and $539.95{\mu}g/m{\ell}$, respectively.

간암 치료 신약 개발 및 이의 제제화 연구 (II. 제제화 연구)

  • 정홍석;최명준;장진수;황유경;안교한;이석종
    • Proceedings of the Korean Society of Applied Pharmacology
    • /
    • 1994.04a
    • /
    • pp.251-251
    • /
    • 1994
  • 1차년도에서 이미 확립한 다양한리포좀의 제조 방법에 따라간세포를표 적하기 위해 이들 리포좀의 조성에 galactocercbroside를 함유시켜 targeted liposomes을 제조하였다. 표적리포좀의 제조 방법에 따른 봉합율 (cncapsulation)과 안정성을 조사했을 때, freezing-thawing 과정을 거친 리포좀이 encapsulation 과 stability가 가장 뛰어남을 알 수 있었다. In vitro 간세포 표적능력을 in vitro cell culture system에서 간세포 cell line (Hep G2, 2.2.15과 다른 cell line (Vero E6, J82)에 대한 표적리포좀과 control liposomes의 uptake를 FTTC 또는 CF 형광으로 측정했을 때, 표적리포좀이 간세포 cell line에 더 많이 uptake하는 것을 알았다. In vivo 실험에서는 6 - 8 주령의 mouse tail vain에 표적리포좀과 control liposomes을 주사하여 각 장기에 존재하는 리포좀의 양을 형광으로 측정했을 때, 표적리포좀 (targetcd liposomes)이 다른 장기에 비해 liver에 선택적으로 많이 분포함을 알수있었다. 또한 간암의 효과적인 치료를 위해 간세포와 암세포를 동시에 표적할 수는 double targeting liposomes을 design 하였다.

  • PDF

Cytotoxicity Assessment of Shellfishes from Domestic Fish Market (국내에서 시판중인 조개류의 세포독성 평가)

  • Kim, Young-Sang;Jayawardena, Thilina U.;An, Lu Yu;Je, Jun-Geon;Nagahawatta, D.P.;Liyanage, N.M.;Jeon, You-Jin
    • Journal of Marine Bioscience and Biotechnology
    • /
    • v.12 no.2
    • /
    • pp.108-114
    • /
    • 2020
  • A variety of shellfish species sold for human consumption are available for purchase in the domestic fish market. The microalgae families inhabit the ocean, where planktons supply the main nutritional resource for the growth of shellfish. Some phytoplanktons produce toxic compounds that are accumulated in shellfish and ultimately cause toxicity in humans. This article reports the cytotoxicity of commercially available shellfish species. Accordingly, hot water extract (HWE) and an aqueous fraction of 50% methanol extract (MEE-AF) showed no significant cytotoxicity on the two cell lines (i.e., HL-60 and Vero cell lines), but 50% methanol extract (MEE) in 3, 6 samples showed 50% cytotoxic effects on HL-60 cells, and 1, 4 samples showed 40%, 20% cytotoxic effects on Vero cells, respectively. In addition, their consequential dichloromethane fractions (MEE-DF) exhibited significant toxicities at the highest concentration (1,000 ㎍/ml) on HL-60 and Vero cells. Since the shellfish samples showed cytotoxicity in the dichloromethane fraction, it is possible that the dichloromethane fraction contains marine toxins. Further research will be needed to identify the toxic components from each sample.

Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex

  • Park, Byoung Kwon;Maharjan, Sony;Lee, Su In;Kim, Jinsoo;Bae, Joon-Yong;Park, Man-Seong;Kwon, Hyung-Joo
    • BMB Reports
    • /
    • v.52 no.6
    • /
    • pp.397-402
    • /
    • 2019
  • Middle East respiratory syndrome coronavirus (MERS-CoV) uses the spike (S) glycoprotein to recognize and enter target cells. In this study, we selected two epitope peptide sequences within the receptor binding domain (RBD) of the MERS-CoV S protein. We used a complex consisting of the epitope peptide of the MERS-CoV S protein and CpG-DNA encapsulated in liposome complex to immunize mice, and produced the monoclonal antibodies 506-2G10G5 and 492-1G10E4E2. The western blotting data showed that both monoclonal antibodies detected the S protein and immunoprecipitated the native form of the S protein. Indirect immunofluorescence and confocal analysis suggested strong reactivity of the antibodies towards the S protein of MERS-CoV virus infected Vero cells. Furthermore, the 506-2G10G5 monoclonal antibody significantly reduced plaque formation in MERS-CoV infected Vero cells compared to normal mouse IgG and 492-1G10E4E2. Thus, we successfully produced a monoclonal antibody directed against the RBD domain of the S protein which could be used in the development of diagnostics and therapeutic applications in the future.

간암 치료 신약 개발 및 이의 제제화 연구(II. 제제화 연구)

  • 최명준;정홍석;장진수;황유경;안교한;이석종
    • Proceedings of the Korean Society of Applied Pharmacology
    • /
    • 1993.04a
    • /
    • pp.65-65
    • /
    • 1993
  • 봉합율의 최적 조건을 구하기 위해 다양한 방법으로 리포좀을 제조했으며, 인지질과 봉합 약물의 비는 20:1 이상이어야 하고, 리포좀 제조 방법에 따라 봉합율이 차이가 났으며, REV, REV를 freezing-thawing한 것과 SUV를 freezing-thawing한 리포좀에서 봉합율이 좋았다. REV를 freezing-thawing한 리포좀이 가장 좋았다 (66.7%, BPB; 115.7 ug trypsin/mg lipid). 콜레스테롤의 함량은 봉합율과 안정성을 고려하여 인지 질과의 비를 7.3으로 고정시켰다. 안정성은 투과성, light scattering, qucnching 등으로 측정했으며,4$^{\circ}C$,용액 상태에서 두 달 이상동안 보관했을 때 약 10% 정도가 리포좀 내에서 빠져나왔으며, 리포좀의 크기 변화는 거의 일어나지 않았다. Calcein봉합 리포좀을 Vero E6 cell에 투여했을 때, 매우 적은 양이 cell내로 들어가는 것을 형광 현미경으로 확인할 수 있었다.

  • PDF

Abiraterone Acetate Attenuates SARS-CoV-2 Replication by Interfering with the Structural Nucleocapsid Protein

  • Kim, Jinsoo;Hwang, Seok Young;Kim, Dongbum;Kim, Minyoung;Baek, Kyeongbin;Kang, Mijeong;An, Seungchan;Gong, Junpyo;Park, Sangkyu;Kandeel, Mahmoud;Lee, Younghee;Noh, Minsoo;Kwon, Hyung-Joo
    • Biomolecules & Therapeutics
    • /
    • v.30 no.5
    • /
    • pp.427-434
    • /
    • 2022
  • The drug repurposing strategy has been applied to the development of emergency COVID-19 therapeutic medicines. Current drug repurposing approaches have been directed against RNA polymerases and viral proteases. Recently, we found that the inhibition of the interaction between the SARS-CoV-2 structural nucleocapsid (N) and spike (S) proteins decreased viral replication. In this study, drug repurposing candidates were screened by in silico molecular docking simulation with the SARS-CoV-2 structural N protein. In the ChEMBL database, 1994 FDA-approved drugs were selected for the in silico virtual screening against the N terminal domain (NTD) of the SARS-CoV-2 N protein. The tyrosine 109 residue in the NTD of the N protein was used as the center of the ligand binding grid for the docking simulation. In plaque forming assays performed with SARS-CoV-2 infected Vero E6 cells, atovaquone, abiraterone acetate, and digoxin exhibited a tendency to reduce the size of the viral plagues without affecting the plaque numbers. Abiraterone acetate significantly decreased the accumulation of viral particles in the cell culture supernatants in a concentration-dependent manner. In addition, abiraterone acetate significantly decreased the production of N protein and S protein in the SARS-CoV-2-infected Vero E6 cells. In conclusion, abiraterone acetate has therapeutic potential to inhibit the viral replication of SARS-CoV-2.